Refractory de novo myeloid sarcoma: a case report and therapeutic strategy based on bone marrow minimal residual disease.
Inoue
Daichi
D
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan. daichi@kcgh.gr.jp.
Nagai
Yuya
Y
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
Kimura
Takaharu
T
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
Shimoji
Sonoko
S
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
Mori
Minako
M
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
Togami
Katsuhiro
K
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
Tabata
Sumie
S
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
Kurata
Masayuki
M
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
Matsushita
Akiko
A
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
Ito
Kiminari
K
Department of Cell Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan.
Hashimoto
Hisako
H
Department of Cell Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan.
Maruoka
Hayato
H
Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
Yamashita
Eiko
E
Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
Nagai
Kenichi
K
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
Imai
Yukihiro
Y
Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.
Shirane
Hirohumi
H
Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.
Takahashi
Takayuki
T
Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
D000293:Adolescent; D019046:Bone Marrow Neoplasms / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000473:pathology / Q000628:therapy*; D008297:Male; D018365:Neoplasm, Residual; D023981:Sarcoma, Myeloid / Q000473:pathology / Q000628:therapy*